TUDOR INVESTMENT CORP ET AL - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$105,151
+8956.9%
13,533
-87.2%
0.00%
-94.4%
Q1 2023$1,161
+541.4%
105,952
+153.2%
0.02%
+350.0%
Q4 2022$181
-100.0%
41,839
-32.9%
0.00%
-75.0%
Q2 2022$627,000
-12.1%
62,369
+100.1%
0.02%
+33.3%
Q4 2021$713,000
+101.4%
31,176
+94.8%
0.01%
+100.0%
Q3 2021$354,00016,0000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders